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Treatment of Chronic Fatigue Syndrome:  
Findings, Principles and Strategies 
 
 
 
Chronic fatigue syndrome (CFS) is a debilitating condition characterized by serious me-
dically unexplained mental and physical fatigue. The high prevalence and both direct and 
indirect health costs of CFS patients represent a huge problem for contemporary health 
care. Moreover, the prognosis of CFS, even when treated, is often poor. In this paper, we first 
critically review current evidence based treatments of CFS. Second, we discuss the growing 
insights into the etiopathogenesis of CFS, and the need to translate and integrate these insights 
into future treatments. In particular, we formulate a pragmatic and empirically testable treat-
ment approach, tailored to the individual needs of patients, which aims at restoring the mental 
and physical equilibrium of CFS patients by trying to bring about sustained life style changes. 
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Introduction 
 
Chronic fatigue syndrome (CFS) is a condition characterized by serious medi-
cally unexplained mental and physical fatigue of at least 6 months duration, accom-
panied by sleep disturbances, poor concentration and flu-like symptoms.
1 CFS re-
presents a huge problem for contemporary health care because of its high prevalence 
(estimates vary between 0.5 to 2.5% in the general population),
2,3 but also because 
of the associated physical and psychosocial disability, leading to high direct as well
as indirect medical and societal costs. Moreover, both clinical experience
4 and research
5
indicate that CFS is often difficult to treat. 
In this paper, we therefore first critically review current evidence based treatments
of CFS. Second, we discuss the growing insights into the etiopathogenesis of CFS,
and the need to translate these insights into treatment principles and strategies. Based
on these considerations, we formulate a pragmatic and empirically testable treatment
model that may be integrated into current evidence based treatments. In particular, this
approach focuses on the tailoring of treatment for CFS patients, and aims at restoring
mental and physical equilibrium in the long-run by trying to accomplish sustained 
changes in life style. 
 
Evidence Based Treatments 
for Chronic Fatigue Syndrome 
 
In the absence of causative therapies, a wide variety of treatment approaches for 
CFS have been suggested, including pharmacological, nutritional, immunological, ex-
ercise and psychosocial treatments. However, recent meta-analyses and reviews have
found that only cognitive behavioral therapy (CBT) and graded exercise treatment
(GET) can be considered as evidence based treatments.
6-9 In particular, on average 
40-50% of CFS patients show clinical improvement in fatigue after CBT or GET com-   
 
 
 
 
Treatment of Chronic Fatigue Syndrome 
210 Psychiatry Invest 2008;5:209-212 
pared to about 20-30% in usual care.
8,10 
However, many questions remain about the therapeutic 
aims, strategies and outcomes, as well as the purported 
mechanisms of change in these treatments. First, success 
rates of both CBT and GET leave considerable room for 
improvement, particularly as studies on the long-term ef-
fects of these treatments have yielded mixed conclusions.
10 
Together with the chronic and relapsing nature of CFS, 
these findings suggest that future studies should investi-
gate the efficacy of maintenance treatment, which may 
help patients to change maladaptive core assumptions and 
achieve lasting life style changes.
11 Second, concerns have 
been raised about the generalisability of results based on 
randomized, controlled clinical trials (RCTs) to routine 
clinical practice. Randomized trials typically include pa-
tients that are more mobile and show less psychiatric co-
morbidity.
10 Moreover, patients in RCTs may be more 
motivated, while therapists may have higher levels of 
training, than in routine practice. Congruent with these 
assumptions, the only study that investigated the effect 
of CBT for CFS within versus outside the confines of an 
RCT found that whereas 63% of the patients in the RCT 
condition no longer met the fatigue caseness criterion, 
only 36% of patients did so in routine clinical care.
12 Third, 
there is little evidence supporting the putative mechanisms 
of change in CBT and GET.
10,13 This has led some resear-
chers to speculate that, as for many psychological problems, 
patient,
14 therapist,
5,15 and common factors such as a emo-
tional processing or the quality of the therapeutic alliance
16 
may be more important in predicting outcome than specific 
techniques associated with particular ‘brand names’ of 
therapy. Although further research is needed, these assump-
tions are congruent with findings that other treatments 
such as mindfulness-based treatment and counseling have 
been shown to lead to comparable effect sizes as CBT 
and GET in the treatment of CFS.
17 Finally, psychologi-
cal treatments such as CBT and GET are often not accep-
table for CFS patients, and many patients therefore seek 
alternative treatments such as homeopathy
18 or dubious 
experimental biological treatments, often through the in-
ternet.
19 
Hence, despite considerable progress in the treatment 
of CFS, much remains to be investigated. In the mean time, 
pragmatic treatment programs should be developed, tak-
ing into account not only treatment outcome studies, but 
also progress in research concerning the etiopathogene-
sis of CFS and related conditions.
20 
 
Chronic Fatigue Syndrome and  
Stress-Related Disorders 
 
Although the etiology of CFS largely remains elusive, 
there is increasing evidence that CFS belongs to the spec-
trum of ‘Stress Intolerance and Pain Hypersensitivity’ 
(SIPH) syndromes,
21 characterized by a persisting in-
ability to tolerate and recover from stress in the broad 
sense of the word (i.e., including physical and mental ef-
fort; sensory overload), and pathological pain processing. 
In particular, there is increasing evidence that the com-
mon pathophysiology of CFS and other stress-related 
disorders mainly consists of a dysfunction of the stress 
system. This dysfunction most likely involves changes in 
the reactivity of the hypothalamic-pituitary-adrenal (HPA) 
axis as well as disturbances in brain neurotransmitter 
balances (particularly serotonin and norepinephrine),
9,22 
which may be in part genetically determined.
23,24 In par-
ticular, it is hypothesized that pathogenesis of these dis-
orders might involve a HPA axis ‘switch’ of the from 
hyper- to hypofunction following a chronic or intense pe-
riod of physical and/or psychosocial stress,
25 leading to 
disturbed stress reactivity, and abnormal inflammatory 
activity which may be responsible for the ‘sickness be-
haviour’ that is often observed in these patients. More spe-
cifically, pro-inflammatory cytokines may lead to feelings 
of lethargia, increased fatigability, loss of concentration, 
generalised hyperalgesia and further hypersensitivity to 
stress, as well as a tendency to withdraw from the outside 
world.
26 
The assumption of a common pathophysiology in SIPH 
disorders is further supported by studies showing sub-
stantial co-occurrence among different functional somatic 
syndromes,
27 such as CFS, fibromyalgia (FM) and ir-
ritable bowel syndrome
27,28 as well as their overlap with 
affective spectrum disorders as expressed in high com-
orbidity and familial coaggregation with depression and 
anxiety.
29-34  
 
Towards a Pragmatic Treatment 
Approach of Chronic Fatigue 
Syndrome: Principles and Strategies 
 
The current limitations of evidence based treatments 
for CFS and the growing knowledge of the etiopathoge-
nesis of CFS both emphasize the need to refine treatment 
approaches of CFS based on the following two principles. 
The first principle entails that patients should receive 
a diagnostic label that subsumes their complaints within 
a broader set of SIPH disorders, characterized by stress 
intolerance and pain hypersensitivity. The advantage of 
such a label above the descriptive diagnosis of CFS is 
that it not only is in line with our current understanding of 
the etiopathogenesis of CFS, but also provides patients 
with a plausible illness theory that is not dualistic, and 
that also provides a plausible theory of recovery and per- 
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haps cure. For instance, patients should be informed that 
their symptoms result from a loss of resilience of their 
stress system, most probably because of chronic burden 
or overload, which also has led to disturbances in their 
immune and pain systems. Moreover, whatever the origin 
of this loss of resilience, patients should be reassured that 
they can substantially contribute to the recovery of their 
stress system by finding a new equilibrium, which involves 
acknowledging and understanding their limitations and 
includes learning to better ‘listen to their body’. This ‘bio-
psychosocial’ view may help patients to accept their con-
dition and understand its multifactorial nature, but also 
help them work through the loss of a previous, and often 
overactive, life style. Finally, the idea that change will 
entail a long-term process of adjustment of lifestyle and 
life goals should be emphasized.
35 
The second principle involves the tailoring of treatment 
to individual patients. It has become clear by now that 
CFS is a heterogeneous condition.
35,36 Besides optimal 
symptom control, including adequate treatment of psy-
chiatric co-morbidities (e.g. antidepressants for associated 
depression and anxiety disorders
37), individually tailored 
strategies that aim at promoting the recovery of the stress 
system should be integrated in current evidence based 
treatments or offered as complementary treatments. For 
instance, whereas for most CFS patients activity pacing 
might be helpful to prevent so-called outbursts of acti-
vity followed by post-exertional malaise, in some patients 
the focus must be on rebuilding physical condition, often 
by overcoming ‘fear of movement’.
20 In other patients, 
dysfunctional beliefs, such as catastrophizing, must be 
addressed. More directive treatments such as CBT
14 or 
mindfulness and acceptance based strategies
38 might work 
best for some patients. Other patients, however, might need 
less directive treatments, such as counselling,
17,39 psycho-
dynamic treatment,
40,41 or systemic interventions
42 to ad-
dress psychiatric comorbidity, personality and/or relati-
onal problems, and to adjust life goals and work through 
the “loss of a life style”. Moreover, such tailored treat-
ments best occur based on a coherent treatment plan wi-
thin the context of a multidisciplinary approach
39 that also 
addresses medical-social issues, as these may consider-
ably influence the treatment process.
14 
 
Conclusions 
 
Notwithstanding considerable advances in the treat-
ment of CFS, current evidence based treatments clearly 
provide no panacea. In particular, more research is needed 
concerning the long-term effects of these treatments, their 
generalisability to routine clinical care, and the identifi-
cation of their mechanisms of change. In the meantime, 
a pragmatic treatment approach is proposed that can be 
integrated in current evidence based treatments of CFS. 
This treatment approach emphasizes the need to incor-
porate findings concerning the etiopathogenesis of CFS 
into treatment, as well as tailoring treatment to indivi-
dual patients.   
This approach, it is believed, will help find patients a 
new mental and physical equilibrium by adjusting their 
life style and life goals. Further research, however, is 
needed to test these assumptions, and particularly to 
find out “what works for whom”.
43 Yet, it is likely that 
in the near future, new treatments that are based on our 
increasing insights into the etiopathogenesis of CFS will 
emerge. 
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